# Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts

> **NCT05761002** · NA · UNKNOWN · sponsor: **Zagazig University** · enrollment: 58 (estimated)

## Conditions studied

- Human Papilloma Virus
- Anogenital Wart

## Interventions

- **BIOLOGICAL:** the Quadrivalent Vaccine (Gardasil)

## Key facts

- **NCT ID:** NCT05761002
- **Lead sponsor:** Zagazig University
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-01
- **Primary completion:** 2023-06-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2023-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05761002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05761002, "Human Papilloma Virus Genotypes and Treatment Outcomes of Intralesional Immunotherapy of Anogenital Warts". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05761002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*